Preformed Line Products Company (PLPC)
Official siteINDUSTRIALS • ELECTRICAL EQUIPMENT & PARTS • NASDAQ
Market Cap: $1.40B
Last updated: Nov 17, 2026 at 11:05 AM ET
Preformed Line Products Company (PLPC) Financials: Revenue, Profit and Cash Flow
Preformed Line Products Company reported revenue of $669.34M for the fiscal year ended Dec 31, 2025, up 12.7% from the year before. That year, net income was $35.31M with a net margin of 5.3%, operating cash flow was $73.47M and free cash flow was $33.34M. The quarter ended Sep 30, 2026 had revenue of $209.50M and net income of $18.02M.
Revenue and Margins
The operating margin was 8.2% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $336.63M, a compound annual rate of 7.9%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $669.34M | +12.7% | 31.2% | 8.2% | 5.3% |
| Dec 2024 | $593.71M | -11.3% | 32.0% | 8.5% | 6.3% |
| Dec 2023 | $669.68M | +5.1% | 35.1% | 12.6% | 9.5% |
| Dec 2022 | $637.02M | +23.1% | 33.8% | 10.9% | 8.5% |
| Dec 2021 | $517.42M | +10.9% | 32.1% | 9.2% | 6.9% |
| Dec 2020 | $466.45M | +4.9% | 33.0% | 8.6% | 6.4% |
| Dec 2019 | $444.86M | +5.7% | 31.6% | 7.3% | 5.2% |
| Dec 2018 | $420.88M | +11.3% | 31.4% | 7.8% | 6.3% |
| Dec 2017 | $378.21M | +12.4% | 31.4% | 6.9% | 3.3% |
| Dec 2016 | $336.63M | N/A | 32.5% | 6.4% | 4.5% |
Income Statement
In the fiscal year ended Dec 2025, net income fell 4.9% from the year before. In the quarter ended Sep 2026, net income rose 587.8% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $669.34M | $593.71M | $669.68M | $637.02M | $517.42M | $466.45M | $444.86M | $420.88M | $378.21M | $336.63M |
| Cost of revenue | $460.80M | $403.90M | $434.83M | $421.84M | $351.18M | $312.44M | $304.27M | $288.65M | $259.58M | $227.22M |
| Gross profit | $208.54M | $189.81M | $234.85M | $215.18M | $166.24M | $154.01M | $140.59M | $132.23M | $118.63M | $109.41M |
| Research and development | $23.69M | $21.92M | $22.48M | $19.66M | $19.19M | $17.63M | $17.19M | $15.11M | $14.33M | $14.03M |
| Operating income | $55.13M | $50.76M | $84.15M | $69.36M | $47.55M | $40.21M | $32.63M | $32.93M | $26.11M | $21.48M |
| Net income | $35.31M | $37.11M | $63.34M | $54.40M | $35.72M | $29.76M | $23.34M | $26.58M | $12.65M | $15.26M |
| EBITDA | $67.64M | $71.25M | $103.35M | $92.72M | $66.31M | $56.55M | $46.64M | $45.84M | $39.23M | $33.50M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $209.50M | $212.68M | $176.28M | $173.11M | $178.09M | $169.60M | $148.54M | $167.12M | $146.97M | $138.72M | $140.90M | $145.60M |
| Gross profit | $70.00M | $73.01M | $55.22M | $51.62M | $52.85M | $55.40M | $48.67M | $55.63M | $45.78M | $44.27M | $44.13M | $48.10M |
| Operating income | $24.90M | $27.90M | $13.72M | $11.75M | $13.13M | $17.12M | $13.13M | $17.51M | $10.39M | $11.29M | $11.56M | $6.95M |
| Net income | $18.02M | $21.51M | $10.55M | $8.44M | $2.62M | $12.70M | $11.55M | $10.45M | $7.70M | $9.37M | $9.60M | $6.31M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded total debt of $39.47M by $43.92M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $653.62M | $573.88M | $603.15M | $568.48M | $489.02M | $461.09M | $433.57M | $358.80M | $359.79M | $340.94M |
| Current assets | $363.46M | $315.79M | $324.81M | $328.17M | $272.11M | $256.31M | $231.97M | $214.26M | $207.13M | $189.11M |
| Cash and equivalents | $83.39M | $57.24M | $53.61M | $37.24M | $36.41M | $45.17M | $38.93M | $43.61M | $44.36M | $30.74M |
| Total liabilities | $178.07M | $151.55M | $187.00M | $209.85M | $172.92M | $169.02M | $165.00M | $109.43M | $121.25M | $117.39M |
| Short-term debt | $6.61M | $10.21M | $13.45M | $21.12M | $19.54M | $22.64M | $12.05M | $10.49M | $2.31M | $2.76M |
| Long-term debt | $32.86M | $18.36M | $48.80M | $68.42M | $40.05M | $33.33M | $53.72M | $24.96M | $34.60M | $42.94M |
| Shareholder equity | $475.52M | $422.31M | $416.16M | $358.64M | $316.12M | $292.08M | $268.54M | $249.37M | $238.54M | $223.54M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $742.30M | $697.49M | $661.83M | $653.62M | $644.62M | $631.46M | $592.45M | $573.88M | $591.95M | $572.59M | $586.11M | $603.15M |
| Total liabilities | $229.66M | $202.89M | $188.25M | $178.10M | $178.28M | $170.69M | $156.63M | $151.55M | $162.97M | $156.37M | $172.74M | $187.00M |
| Cash and equivalents | N/A | N/A | $69.45M | $83.39M | $72.95M | $66.91M | $54.84M | $57.24M | $47.50M | $47.42M | $45.86M | $53.61M |
| Shareholder equity | $512.60M | $494.54M | $473.52M | $475.52M | $466.31M | $460.74M | $435.78M | $422.31M | $428.97M | $416.22M | $413.37M | $416.16M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 45.4% of operating cash flow. Dividends and share repurchases together came to 55.7% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $73.47M | $67.48M | $107.64M | $26.15M | $33.60M | $41.64M | $27.22M | $22.98M | $33.83M | $25.97M |
| Capital expenditures | $40.13M | $14.65M | $35.33M | $40.60M | $18.38M | $24.57M | $29.47M | $9.53M | $11.23M | $24.73M |
| Free cash flow | $33.34M | $52.83M | $72.31M | -$14.45M | $15.21M | $17.07M | -$2.25M | $13.45M | $22.60M | $1.25M |
| Dividends paid | $4.12M | $4.08M | $4.11M | $4.10M | $4.13M | $4.18M | $4.23M | $4.09M | $4.10M | $4.17M |
| Share repurchases | $14.46M | $8.61M | $18.89M | $5.47M | $5.27M | $9.46M | $6.83M | $4.17M | $8.48M | $5.07M |
| Investing cash flow | -$43.38M | -$12.36M | -$44.79M | -$46.76M | -$18.24M | -$14.04M | -$48.80M | -$14.02M | -$2.56M | -$28.47M |
| Financing cash flow | -$9.23M | -$47.80M | -$48.92M | $22.54M | -$23.23M | -$23.16M | $17.71M | -$9.05M | -$19.55M | $4.39M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $36.83M | $25.21M | $6.05M | $21.94M | $18.94M | $26.93M | $5.66M | $24.07M | $9.37M | $28.29M | $5.75M | $19.29M |
| Capital expenditures | $26.70M | $6.96M | $9.99M | $10.15M | $10.62M | $8.38M | $10.98M | $3.43M | $3.57M | $3.73M | $3.92M | $8.21M |
| Free cash flow | $10.13M | $18.26M | -$3.95M | $11.79M | $8.32M | $18.55M | -$5.32M | $20.64M | $5.79M | $24.57M | $1.83M | $11.07M |
Frequently Asked Questions About PLPC
What is Preformed Line Products Company's annual revenue?
Preformed Line Products Company reported revenue of $669.34M for the fiscal year ended Dec 31, 2025.
How fast is Preformed Line Products Company's revenue growing?
Revenue was up 12.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 1.7%.
Is Preformed Line Products Company profitable?
Yes. Preformed Line Products Company reported net income of $35.31M for the fiscal year ended Dec 31, 2025, with a net margin of 5.3%.
How much free cash flow does PLPC generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $73.47M minus capital expenditures of $40.13M produced free cash flow of $33.34M.
How much debt does Preformed Line Products Company have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $32.86M, short-term debt of $6.61M and cash and equivalents of $83.39M.
PLPC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors